These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 25134047)
21. Design and implementation of a cohort study of persons living with HIV infection who are initiating medication treatment for opioid use disorder to evaluate HIV-1 persistence. Schultheis A; Sanchez M; Pedersen S; Kyriakides T; Ho YC; Kluger Y; Springer SA Contemp Clin Trials Commun; 2021 Dec; 24():100866. PubMed ID: 34825103 [TBL] [Abstract][Full Text] [Related]
22. Individual differences in addiction-like behaviors and choice between cocaine versus food in Heterogeneous Stock rats. Sedighim S; Carrette LL; Venniro M; Shaham Y; de Guglielmo G; George O Psychopharmacology (Berl); 2021 Dec; 238(12):3423-3433. PubMed ID: 34415376 [TBL] [Abstract][Full Text] [Related]
23. Monitoring and Improving Naltrexone Adherence in Patients with Substance Use Disorder. Perez-Macia V; Martinez-Cortes M; Mesones J; Segura-Trepichio M; Garcia-Fernandez L Patient Prefer Adherence; 2021; 15():999-1015. PubMed ID: 34040354 [TBL] [Abstract][Full Text] [Related]
24. Abstinence-dependent dissociable central amygdala microcircuits control drug craving. Venniro M; Russell TI; Ramsey LA; Richie CT; Lesscher HMB; Giovanetti SM; Messing RO; Shaham Y Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8126-8134. PubMed ID: 32205443 [TBL] [Abstract][Full Text] [Related]
25. Operant Social Reward Decreases Incubation of Heroin Craving in Male and Female Rats. Venniro M; Russell TI; Zhang M; Shaham Y Biol Psychiatry; 2019 Dec; 86(11):848-856. PubMed ID: 31326085 [TBL] [Abstract][Full Text] [Related]
26. Prescription opioid poisoning across urban and rural areas: identifying vulnerable groups and geographic areas. Cerdá M; Gaidus A; Keyes KM; Ponicki W; Martins S; Galea S; Gruenewald P Addiction; 2017 Jan; 112(1):103-112. PubMed ID: 27470224 [TBL] [Abstract][Full Text] [Related]
27. Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation. Adi Y; Juarez-Garcia A; Wang D; Jowett S; Frew E; Day E; Bayliss S; Roberts T; Burls A Health Technol Assess; 2007 Feb; 11(6):iii-iv, 1-85. PubMed ID: 17280624 [TBL] [Abstract][Full Text] [Related]
28. Extended-release intramuscular naltrexone (VIVITROL®): a review of its use in the prevention of relapse to opioid dependence in detoxified patients. Syed YY; Keating GM CNS Drugs; 2013 Oct; 27(10):851-61. PubMed ID: 24018540 [TBL] [Abstract][Full Text] [Related]
29. Employment-based reinforcement of adherence to oral naltrexone in unemployed injection drug users: 12-month outcomes. Dunn K; DeFulio A; Everly JJ; Donlin WD; Aklin WM; Nuzzo PA; Leoutsakos JM; Umbricht A; Fingerhood M; Bigelow GE; Silverman K Psychol Addict Behav; 2015 Jun; 29(2):270-6. PubMed ID: 25134047 [TBL] [Abstract][Full Text] [Related]
30. Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users. Dunn KE; Defulio A; Everly JJ; Donlin WD; Aklin WM; Nuzzo PA; Leoutsakos JM; Umbricht A; Fingerhood M; Bigelow GE; Silverman K Exp Clin Psychopharmacol; 2013 Feb; 21(1):74-83. PubMed ID: 23205722 [TBL] [Abstract][Full Text] [Related]
31. Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial. Everly JJ; DeFulio A; Koffarnus MN; Leoutsakos JM; Donlin WD; Aklin WM; Umbricht A; Fingerhood M; Bigelow GE; Silverman K Addiction; 2011 Jul; 106(7):1309-18. PubMed ID: 21320227 [TBL] [Abstract][Full Text] [Related]
32. Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial. DeFulio A; Everly JJ; Leoutsakos JM; Umbricht A; Fingerhood M; Bigelow GE; Silverman K Drug Alcohol Depend; 2012 Jan; 120(1-3):48-54. PubMed ID: 21782353 [TBL] [Abstract][Full Text] [Related]